In 2021, the Network published its new five-year strategy, as a collective group of AHSNs. It sets out how we will achieve our purpose, to transform lives through innovation through three strategic aims:

Strategic Aim 1: Develop outcomes-led programmes that respond to health and care priorities.

Strategic Aim 2: Build a high-impact national innovation pipeline.

Strategic Aim 3: Establish AHSNs as an authoritative voice on transforming health through the spread of innovation.

The strategy also sets out how we intend to work together as a connected Network, supporting staff across AHSNs to collaborate, learn and develop.

Read the strategy here.

  • Collaborating to improve access and equity of care for sickle cell sufferers

    Harriet Smith is the Health Innovation Network's MTFM National Lead for Spectra Optia. In this blog, she outlines the collaborative efforts to improve the support available to people with sickle cell disease, and tackle long standing inequalities. Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red [...]

  • Until tackling health inequalities becomes business as usual, innovation is our best chance of equity

    Dr Stuart Monk, National Programme Director for the Accelerated Access Collaborative (AAC) Programmes at the Health Innovation Network, talks about the pivotal role of innovation tackling healthcare inequalities in the NHS. At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made [...]

  • Where health innovation is concerned, 15 approaches are better than one

    Dr Phil Jennings, Vice Chair of the Health Innovation Network and Chief Executive of Health Innovation North West Coast, discusses why the Network’s collective relicensing gives innovation a better chance of success. In any one day in England, 1.2 million people attend a GP appointment, over a quarter of a million people have an outpatient [...]